Overview

Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis

Status:
Recruiting
Trial end date:
2022-12-29
Target enrollment:
Participant gender:
Summary
This study is a randomized, double-blind clinical trial in a Chinese population
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Jiangsu XinChen-Techfields Pharma Co., LTD.
Treatments:
Celecoxib